IBDEI2T7 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,44808,2)
;;=^5002533
;;^UTILITY(U,$J,358.3,44809,0)
;;=E08.621^^170^2236^24
;;^UTILITY(U,$J,358.3,44809,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44809,1,3,0)
;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,44809,1,4,0)
;;=4^E08.621
;;^UTILITY(U,$J,358.3,44809,2)
;;=^5002534
;;^UTILITY(U,$J,358.3,44810,0)
;;=T81.33XA^^170^2236^27
;;^UTILITY(U,$J,358.3,44810,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44810,1,3,0)
;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
;;^UTILITY(U,$J,358.3,44810,1,4,0)
;;=4^T81.33XA
;;^UTILITY(U,$J,358.3,44810,2)
;;=^5054476
;;^UTILITY(U,$J,358.3,44811,0)
;;=L60.3^^170^2236^30
;;^UTILITY(U,$J,358.3,44811,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44811,1,3,0)
;;=3^Dystrophic Nails
;;^UTILITY(U,$J,358.3,44811,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,44811,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,44812,0)
;;=M71.30^^170^2236^25
;;^UTILITY(U,$J,358.3,44812,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44812,1,3,0)
;;=3^Digital Mucous Cyst
;;^UTILITY(U,$J,358.3,44812,1,4,0)
;;=4^M71.30
;;^UTILITY(U,$J,358.3,44812,2)
;;=^5013149
;;^UTILITY(U,$J,358.3,44813,0)
;;=L30.4^^170^2237^10
;;^UTILITY(U,$J,358.3,44813,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44813,1,3,0)
;;=3^Erythema Intertrigo
;;^UTILITY(U,$J,358.3,44813,1,4,0)
;;=4^L30.4
;;^UTILITY(U,$J,358.3,44813,2)
;;=^5009157
;;^UTILITY(U,$J,358.3,44814,0)
;;=R60.0^^170^2237^6
;;^UTILITY(U,$J,358.3,44814,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44814,1,3,0)
;;=3^Edema,Localized
;;^UTILITY(U,$J,358.3,44814,1,4,0)
;;=4^R60.0
;;^UTILITY(U,$J,358.3,44814,2)
;;=^5019532
;;^UTILITY(U,$J,358.3,44815,0)
;;=L53.0^^170^2237^14
;;^UTILITY(U,$J,358.3,44815,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44815,1,3,0)
;;=3^Erythema Toxic
;;^UTILITY(U,$J,358.3,44815,1,4,0)
;;=4^L53.0
;;^UTILITY(U,$J,358.3,44815,2)
;;=^5009207
;;^UTILITY(U,$J,358.3,44816,0)
;;=L53.1^^170^2237^9
;;^UTILITY(U,$J,358.3,44816,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44816,1,3,0)
;;=3^Erythema Annulare Centrifugum
;;^UTILITY(U,$J,358.3,44816,1,4,0)
;;=4^L53.1
;;^UTILITY(U,$J,358.3,44816,2)
;;=^5009208
;;^UTILITY(U,$J,358.3,44817,0)
;;=L51.9^^170^2237^12
;;^UTILITY(U,$J,358.3,44817,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44817,1,3,0)
;;=3^Erythema Multiforme,Unspec
;;^UTILITY(U,$J,358.3,44817,1,4,0)
;;=4^L51.9
;;^UTILITY(U,$J,358.3,44817,2)
;;=^336759
;;^UTILITY(U,$J,358.3,44818,0)
;;=L12.35^^170^2237^8
;;^UTILITY(U,$J,358.3,44818,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44818,1,3,0)
;;=3^Epidermolysis Bullosa,Acquired
;;^UTILITY(U,$J,358.3,44818,1,4,0)
;;=4^L12.35
;;^UTILITY(U,$J,358.3,44818,2)
;;=^5009100
;;^UTILITY(U,$J,358.3,44819,0)
;;=L52.^^170^2237^13
;;^UTILITY(U,$J,358.3,44819,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44819,1,3,0)
;;=3^Erythema Nodosum
;;^UTILITY(U,$J,358.3,44819,1,4,0)
;;=4^L52.
;;^UTILITY(U,$J,358.3,44819,2)
;;=^42065
;;^UTILITY(U,$J,358.3,44820,0)
;;=L49.0^^170^2237^26
;;^UTILITY(U,$J,358.3,44820,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44820,1,3,0)
;;=3^Exfoliation d/t Erythematous Cond w/ < 10% Body Surface
;;^UTILITY(U,$J,358.3,44820,1,4,0)
;;=4^L49.0
;;^UTILITY(U,$J,358.3,44820,2)
;;=^5009190
;;^UTILITY(U,$J,358.3,44821,0)
;;=L49.1^^170^2237^17
;;^UTILITY(U,$J,358.3,44821,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2T7 3792 printed Dec 13, 2024@02:35:21 Page 2
IBDEI2T7 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,44808,2)
+2 ;;=^5002533
+3 ;;^UTILITY(U,$J,358.3,44809,0)
+4 ;;=E08.621^^170^2236^24
+5 ;;^UTILITY(U,$J,358.3,44809,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,44809,1,3,0)
+8 ;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
+9 ;;^UTILITY(U,$J,358.3,44809,1,4,0)
+10 ;;=4^E08.621
+11 ;;^UTILITY(U,$J,358.3,44809,2)
+12 ;;=^5002534
+13 ;;^UTILITY(U,$J,358.3,44810,0)
+14 ;;=T81.33XA^^170^2236^27
+15 ;;^UTILITY(U,$J,358.3,44810,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,44810,1,3,0)
+18 ;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
+19 ;;^UTILITY(U,$J,358.3,44810,1,4,0)
+20 ;;=4^T81.33XA
+21 ;;^UTILITY(U,$J,358.3,44810,2)
+22 ;;=^5054476
+23 ;;^UTILITY(U,$J,358.3,44811,0)
+24 ;;=L60.3^^170^2236^30
+25 ;;^UTILITY(U,$J,358.3,44811,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,44811,1,3,0)
+28 ;;=3^Dystrophic Nails
+29 ;;^UTILITY(U,$J,358.3,44811,1,4,0)
+30 ;;=4^L60.3
+31 ;;^UTILITY(U,$J,358.3,44811,2)
+32 ;;=^5009236
+33 ;;^UTILITY(U,$J,358.3,44812,0)
+34 ;;=M71.30^^170^2236^25
+35 ;;^UTILITY(U,$J,358.3,44812,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,44812,1,3,0)
+38 ;;=3^Digital Mucous Cyst
+39 ;;^UTILITY(U,$J,358.3,44812,1,4,0)
+40 ;;=4^M71.30
+41 ;;^UTILITY(U,$J,358.3,44812,2)
+42 ;;=^5013149
+43 ;;^UTILITY(U,$J,358.3,44813,0)
+44 ;;=L30.4^^170^2237^10
+45 ;;^UTILITY(U,$J,358.3,44813,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,44813,1,3,0)
+48 ;;=3^Erythema Intertrigo
+49 ;;^UTILITY(U,$J,358.3,44813,1,4,0)
+50 ;;=4^L30.4
+51 ;;^UTILITY(U,$J,358.3,44813,2)
+52 ;;=^5009157
+53 ;;^UTILITY(U,$J,358.3,44814,0)
+54 ;;=R60.0^^170^2237^6
+55 ;;^UTILITY(U,$J,358.3,44814,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,44814,1,3,0)
+58 ;;=3^Edema,Localized
+59 ;;^UTILITY(U,$J,358.3,44814,1,4,0)
+60 ;;=4^R60.0
+61 ;;^UTILITY(U,$J,358.3,44814,2)
+62 ;;=^5019532
+63 ;;^UTILITY(U,$J,358.3,44815,0)
+64 ;;=L53.0^^170^2237^14
+65 ;;^UTILITY(U,$J,358.3,44815,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,44815,1,3,0)
+68 ;;=3^Erythema Toxic
+69 ;;^UTILITY(U,$J,358.3,44815,1,4,0)
+70 ;;=4^L53.0
+71 ;;^UTILITY(U,$J,358.3,44815,2)
+72 ;;=^5009207
+73 ;;^UTILITY(U,$J,358.3,44816,0)
+74 ;;=L53.1^^170^2237^9
+75 ;;^UTILITY(U,$J,358.3,44816,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,44816,1,3,0)
+78 ;;=3^Erythema Annulare Centrifugum
+79 ;;^UTILITY(U,$J,358.3,44816,1,4,0)
+80 ;;=4^L53.1
+81 ;;^UTILITY(U,$J,358.3,44816,2)
+82 ;;=^5009208
+83 ;;^UTILITY(U,$J,358.3,44817,0)
+84 ;;=L51.9^^170^2237^12
+85 ;;^UTILITY(U,$J,358.3,44817,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,44817,1,3,0)
+88 ;;=3^Erythema Multiforme,Unspec
+89 ;;^UTILITY(U,$J,358.3,44817,1,4,0)
+90 ;;=4^L51.9
+91 ;;^UTILITY(U,$J,358.3,44817,2)
+92 ;;=^336759
+93 ;;^UTILITY(U,$J,358.3,44818,0)
+94 ;;=L12.35^^170^2237^8
+95 ;;^UTILITY(U,$J,358.3,44818,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,44818,1,3,0)
+98 ;;=3^Epidermolysis Bullosa,Acquired
+99 ;;^UTILITY(U,$J,358.3,44818,1,4,0)
+100 ;;=4^L12.35
+101 ;;^UTILITY(U,$J,358.3,44818,2)
+102 ;;=^5009100
+103 ;;^UTILITY(U,$J,358.3,44819,0)
+104 ;;=L52.^^170^2237^13
+105 ;;^UTILITY(U,$J,358.3,44819,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,44819,1,3,0)
+108 ;;=3^Erythema Nodosum
+109 ;;^UTILITY(U,$J,358.3,44819,1,4,0)
+110 ;;=4^L52.
+111 ;;^UTILITY(U,$J,358.3,44819,2)
+112 ;;=^42065
+113 ;;^UTILITY(U,$J,358.3,44820,0)
+114 ;;=L49.0^^170^2237^26
+115 ;;^UTILITY(U,$J,358.3,44820,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,44820,1,3,0)
+118 ;;=3^Exfoliation d/t Erythematous Cond w/ < 10% Body Surface
+119 ;;^UTILITY(U,$J,358.3,44820,1,4,0)
+120 ;;=4^L49.0
+121 ;;^UTILITY(U,$J,358.3,44820,2)
+122 ;;=^5009190
+123 ;;^UTILITY(U,$J,358.3,44821,0)
+124 ;;=L49.1^^170^2237^17
+125 ;;^UTILITY(U,$J,358.3,44821,1,0)
+126 ;;=^358.31IA^4^2
